NDC product
Promethazine Hydrochloride and Codeine Phosphate
NDC 27808-065 · Cranbury Pharmaceuticals, LLC
Key facts
| Product NDC | 27808-065 |
|---|---|
| Proprietary name | Promethazine Hydrochloride and Codeine Phosphate |
| Nonproprietary name | Promethazine Hydrochloride and Codeine Phosphate |
| Substances | PROMETHAZINE HYDROCHLORIDE, CODEINE PHOSPHATE |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Cranbury Pharmaceuticals, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA200386 |
| DEA schedule | CV |
| Pharmacologic classes | Full Opioid Agonists [MoA], Opioid Agonist [EPC], Phenothiazine [EPC], Phenothiazines [CS] |
| Marketing start | Mar 12, 2018 |
| Marketing end | Mar 1, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory